Literature DB >> 18781481

Insulin resistance in postmenopausal women: concurrent effects of hormone replacement therapy and coffee.

D Catalano1, G M Trovato, D Spadaro, G F Martines, G Garufi, A Tonzuso, D Grasso, S G Sciacchitano.   

Abstract

BACKGROUND: In postmenopausal women, an increase in insulin resistance is associated with an increased risk of diabetes, cardiovascular disease and breast cancer. Hormone replacement therapy (HRT) can reduce insulin resistance and coffee use is reported to decrease the incidence of diabetes. The aim of our study was to assess possible concurrent effects of HRT and espresso coffee intake on insulin resistance and on interdependent nutritional and clinical features.
METHODS: A total of 478 healthy postmenopausal, non-diabetic women (aged 54.5 +/- 4.2 years) were studied: 360 had been on HRT for at least 2 years and 118 were not treated. Insulin resistance was assessed by a conventional homeostasis model (HOMA-IR).
RESULTS: Insulin resistance is directly related to body mass index (p < 0.0001), and not with age and blood pressure; hypertensive menopausal women have a slightly higher body mass index but the same degree of insulin resistance as normotensive women. Women on HRT show lower insulin resistance, but not lower prevalence of arterial hypertension. Coffee use is associated with a decrease in insulin resistance in non-obese women receiving HRT, but not in other subsets.
CONCLUSIONS: The combination of coffee consumption and HRT could lower insulin resistance in postmenopausal women. In overweight women, greater insulin sensitivity is associated with intake of espresso coffee and not with HRT; in normal weight women, only HRT is associated with lower insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781481     DOI: 10.1080/13697130802348728

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  6 in total

1.  Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine.

Authors:  Guglielmo M Trovato
Journal:  EPMA J       Date:  2012-03-22       Impact factor: 6.543

2.  Variation in the CYP19A1 gene and risk of colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Susan Kadlubar; Bette J Caan; John D Potter; Roger K Wolff
Journal:  Cancer Causes Control       Date:  2011-04-11       Impact factor: 2.506

3.  Analysis of the degree of insulin resistance in post menopausal women by using skin temperature measurements and fasting insulin and fasting glucose levels: a case control study.

Authors:  Sathya Bhama C V; Balaji S; Seethalakshmi A
Journal:  J Clin Diagn Res       Date:  2012-12-15

4.  Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).

Authors:  Daniela Catalano; Giuseppe Fabio Martines; Antonia Tonzuso; Clara Pirri; Francesca M Trovato; Guglielmo M Trovato
Journal:  Dig Dis Sci       Date:  2010-02-18       Impact factor: 3.199

5.  The Relationship Between Menopause and Metabolic Syndrome: Experimental and Bioinformatics Analysis.

Authors:  Abir Jaballah; Ismael Soltani; Wael Bahia; Azza Dandana; Yosra Hasni; Abdelhedi Miled; Salima Ferchichi
Journal:  Biochem Genet       Date:  2021-05-10       Impact factor: 1.890

Review 6.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.